SCHEMBL6737115

SCHEMBL6737115

CCCCCCOc1ccc(S(=O)(=O)C(=[N+]=[N-])S(=O)(=O)c2ccc(C)cc2C)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDIA6 Q15084 1/20 0.41
TSHR P16473 2/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA7 P43166 1/20 0.40
CA9 Q16790 1/20 0.40
PLK1 P53350 3/20 0.40
NR5A1 Q13285 1/20 0.39
TP53 P04637 1/20 0.39
PLA2G4B P0C869 1/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 1/20 0.38
MMP3 P08254 1/20 0.37
MMP9 P14780 1/20 0.37
MMP13 P45452 1/20 0.37
ADAM17 P78536 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
S1PR1 P21453 1/20 0.37
RARB P10826 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6741894 1.00 PDIA6 (0.41) PDIA6TSHRCA12CA1CA2
SCHEMBL5882011 0.92 RAPGEF3 (0.45) PDIA6TSHRCA12CA1CA2
SCHEMBL6739114 0.89 TSHR (0.48) TSHRCA12CA1CA2CA7
SCHEMBL6736717 0.89 TSHR (0.48) TSHRCA12CA1CA2CA7
SCHEMBL5882013 0.88 RAPGEF3 (0.47) PDIA6TSHRCA12CA1CA2
SCHEMBL6738526 0.88 PDIA6 (0.53) PDIA6TSHRNR5A1TP53PLA2G4B
SCHEMBL385151 0.88 PDIA6 (0.53) PDIA6TSHRNR5A1TP53PLA2G4B
SCHEMBL6744176 0.88 PDIA6 (0.53) PDIA6TSHRNR5A1TP53PLA2G4B
SCHEMBL30667567 0.88 PDIA6 (0.53) PDIA6TSHRNR5A1TP53PLA2G4B
SCHEMBL6741835 0.88 PDIA6 (0.53) PDIA6TSHRNR5A1TP53PLA2G4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6689530-B2 ULTRAVIOLET LITHOGRAPHY MICROFABRICATION WITH IMPROVED RESOLUTION AND PATTERN PROFILE AFTER DEVELOPMENT SHIN-ETSU CHEMICAL CO., LTD. (JP) 2004-02-10 US disclosed
US-20030180653-A1 Novel sulfonyldiazomethanes, photoacid generations, resist compositions, and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2003-09-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030180653-A1 Novel sulfonyldiazomethanes, photoacid generations, resist compositions, and patterning process CACNA1A, KCNA1, POLL PDIA6 2603/4885TSHR 3831/4885CA12 2936/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.